February 23, 2021 – The U.S. Preventive Services Task Force seeks comments on a draft recommendation statement and draft evidence review on aspirin use to prevent preeclampsia and related morbidity and mortality. The Task Force recommends low-dose aspirin for pregnant people at increased risk. The draft recommendation statement and draft evidence review are available for review and public comment from February 23, 2021 to March 22, 2021 here.
